ShareValue.ai

ShareValue scores for MYO: Valuation 50, Quality 54, Growth 70, Health 47.

MYO
NYSE American

Myomo Inc

$1.15(-16.06%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
50
Fair Value
Price vs Value
Quality
54
Moderate
Business Strength
Growth
70
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
70
Bullish
Price Trend

Company Details

About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Score Analysis

AI Investment Thesis

Data as of:Jun 15, 2026
|
Last calculated:Jun 15, 2026